Adagio Medical's Board Completes Strategic Review And Has Initiated A Formal Process To Explore Alternatives To Maximize Shareholder Value; May Include Acquisition, Merger, Business Combination, Or Other Transaction

Adagio Medical's Board of Directors has completed a strategic review and initiated a formal process to explore alternatives aimed at maximizing shareholder value, which may include an acquisition, merger, or other transactions. The company is also implementing a workforce reduction to align its cost structure with prioritized programs. As of June 30, 2026, Adagio reported approximately $7.7 million in cash, cash equivalents, and investments in marketable securities.